Kidney produces a novel acylated peptide, ghrelin

[1]  K. Kangawa,et al.  Purification and Characterization of Rat des-Gln14-Ghrelin, a Second Endogenous Ligand for the Growth Hormone Secretagogue Receptor* , 2000, The Journal of Biological Chemistry.

[2]  M. Nakazato,et al.  Ghrelin is a growth-hormone-releasing acylated peptide from stomach , 1999, Nature.

[3]  M. Bernareggi,et al.  Growth Hormone-Independent Cardioprotective Effects of Hexarelin in the Rat1. , 1999, Endocrinology.

[4]  S. Narumiya,et al.  Roles of prostaglandin E receptors in mesangial cells under high-glucose conditions. , 1999, Kidney international.

[5]  N. Tamura,et al.  Isolation and Characterization of CA XIV, a Novel Membrane-bound Carbonic Anhydrase from Mouse Kidney* , 1999, The Journal of Biological Chemistry.

[6]  F. Casanueva,et al.  Growth Hormone Secretagogues: Physiological Role and Clinical Utility , 1999, Trends in Endocrinology & Metabolism.

[7]  R. Zeller,et al.  Rearrangements of the cytoskeleton and cell contacts induce process formation during differentiation of conditionally immortalized mouse podocyte cell lines. , 1997, Experimental cell research.

[8]  Roy G. Smith,et al.  Distribution of mRNA encoding the growth hormone secretagogue receptor in brain and peripheral tissues. , 1997, Brain research. Molecular brain research.

[9]  M. Phillips,et al.  Molecular analysis of rat pituitary and hypothalamic growth hormone secretagogue receptors. , 1997, Molecular endocrinology.

[10]  S. Feld,et al.  Growth hormone, the insulin-like growth factor system, and the kidney. , 1996, Endocrine reviews.

[11]  Patrick R. Griffin,et al.  A Receptor in Pituitary and Hypothalamus That Functions in Growth Hormone Release , 1996, Science.

[12]  S. Narumiya,et al.  Molecular cloning and expression of multiple isoforms of human prostaglandin E receptor EP3 subtype generated by alternative messenger RNA splicing: multiple second messenger systems and tissue-specific distributions. , 1995, Molecular pharmacology.

[13]  S. Schwartz,et al.  Adverse Effects of Recombinant Human Insulin-like Growth Factor I in Obese Insulin-Resistant Type II Diabetic Patients , 1994, Diabetes.

[14]  M. Baum,et al.  Effects of growth hormone and insulin-like growth factor I on rabbit proximal convoluted tubule transport. , 1991, The Journal of clinical investigation.

[15]  M. Hammerman,et al.  Insulin-like growth factors I and II are produced in the metanephros and are required for growth and development in vitro , 1991, The Journal of cell biology.

[16]  A. E. El Nahas,et al.  Nitric oxide synthesis inhibitor prevents vasodilation by insulin-like growth factor I. , 1991, Kidney international.

[17]  J. Kopple,et al.  Evidence that insulin-like growth factor I increases renal plasma flow and glomerular filtration rate in fasted rats. , 1989, The Journal of clinical investigation.

[18]  R. Palmiter,et al.  Regulation of insulin-like growth factor I gene expression by growth hormone. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[19]  H. Preuss,et al.  Tubulointerstitial diseases. , 1980, American family physician.